Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-11.99	1400.88	1591.71
Graham Fair Price	-11.44	0.19	0.22
PEG	-176.03	-17.68	-6.41
Price/Book	-33.75	13.17	19.88
Price/Cash Flow	12.06	-186.82	-212.45
Prices/Earnings	-14.16	413.90	482.20
Price/Sales	-25.53	41.07	55.14
Price/FCF	12.06	-186.82	-212.45
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	21.93	0.06	0.05
Operating Margin	-20.08	0.03	0.03
ROA	-24.34	< 0.005	< 0.005
ROE	0.01	< 0.005	-22.82
ROIC	< 0.005	< 0.005	-35.48
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	14.83	-0.11	13264.82
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.66	-0.28	56.82
EPS QOQ	-0.75	-0.23	68.90
FCF QOQ	-1.42	0.24	-83.03
Revenue QOQ	-0.49	-0.10	78.86
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	55.34	84.00	51.77
Days Sales Outstanding (DSO)	191.63	214.95	12.17
Inventory Turnover	1.63	1.07	-34.11
Debt/Capitalization	< 0.005	0.08	1356.67
Quick Ratio	6.16	6.56	6.48
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.45	0.47	4.07
Cash	0.04	0.04	0.85
Capex	0.00	< 0.005	100.00
Free Cash Flow	-0.04	-0.03	24.06
Revenue	0.16	0.15	-10.33
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	8.09	8.70	7.57
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-6.00	0.37	-93.86
Naive Interpretation	Member

06 - Financial Health · Bad

Rating